🔗 Share this article

Treasury head Reeves has revealed she is planning "targeted measures to address cost of living pressures" in next month's Budget.

During an interview with the BBC, she stated that lowering inflation is a collective task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the most elevated among the G7 developed nations this year and next.

Potential Energy Cost Interventions

It is understood the government could intervene to reduce utility costs, for instance by reducing the present 5% rate of value-added tax charged on energy supplies.

A further option is to cut some of the regulatory levies presently included in bills.

Fiscal Constraints and Expert Predictions

The administration will obtain the next draft from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much scope there is for such actions.

The consensus from most experts is that Reeves will have to announce higher taxes or expenditure reductions in order to adhere to her self-imposed fiscal targets.

Earlier on Thursday, analysis showed there was a £22bn shortfall for the Treasury chief to fill, which is at the more modest range of projections.

"There's a shared task between the Bank of England and the government to continue tackling some of the causes of price increases," the Chancellor told the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While much of the attention has been on probable tax rises, the chancellor said the most recent figures from the fiscal watchdog had not altered her pledge to election pledges not to raise tax levels on earnings tax, VAT or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and commercial concerns for the Budget tax moves, likely to be directed on those "wealthiest."

Global Trade Disputes

Commenting on concerns about the United Kingdom's trade ties with the Asian nation she said: "Our security interests always take priority."

Recent declaration by China to increase trade restrictions on critical minerals and other materials that are key for high-technology production led US President Donald Trump to suggest an additional 100% import tax on goods from China, raising the possibility of an full-scale trade war between the two largest economies.

The US Treasury Secretary described the Chinese move "economic coercion" and "a global supply chain power grab."

Questioned on accepting the American proposal to join its battle with the Asian nation, Reeves said she was "very concerned" by Chinese actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "damaging for the world economy and creates additional headwinds."

"In my view there are areas where we should challenge China, but there are also important opportunities to trade with Chinese markets, including financial services and other areas of the economy. We've got to achieve that balance appropriate."

The chancellor also stated she was working with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

The Chancellor also recognized that the cost the NHS pays for drugs could increase as a result of current talks with the US government and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either halting or canceling operations in the United Kingdom, with several blaming the modest returns they are obtaining.

Last month, the Science Minister said the cost the NHS pays for drugs would must rise to halt companies and drug research funding departing from the UK.

The Chancellor told media: "It has been observed because of the payment system, that drug testing, innovative medicines have not been available in the UK in the way that they are in other European countries."

"The objective is to guarantee that patients receiving care from the National Health Service are able to obtain the best critical drugs in the globe. And so we are looking at these issues, and... aiming to attract increased capital into Britain."